Clinical Trials Browser

Carcinoma, Basal Cell, Lentigo, Melanoma, Nevus, Keratosis, Seborrheic, Hutchinson's Melanotic Freckle

NCT02394132 2024-06-20

RADICAL

Phase 3 Completed

126 enrolled

Hutchinson's Melanotic Freckle

NCT02723721 2023-11-18

PICAMEL

Phase 2 Completed

20 enrolled

Hutchinson's Melanotic Freckle

NCT04688749 2023-07-25

DermaSense

Terminated

50 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Carcinosarcoma, Dysplastic Nevus Syndrome, Melanoma, Neoplasms, Keratosis, Seborrheic, Hutchinson's Melanotic Freckle

NCT03508297 2021-11-12

Reflectance Confocal Microscopy to Diagnose MM & LM

Completed

597 enrolled

Dermatologic

Melanoma, Skin Neoplasms, Hutchinson's Melanotic Freckle

NCT01088737 2019-08-13

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Phase 2/3 Unknown

60 enrolled

Dermatologic

Melanoma, Hutchinson's Melanotic Freckle

NCT02306512 2019-01-07

Mohs and Immunofluorescence for Malignant Melanoma In Situ

Phase NA Withdrawn

Hutchinson's Melanotic Freckle

NCT02685592 2018-05-30

LM PDT

Phase 4 Completed

10 enrolled

Hutchinson's Melanotic Freckle

NCT00785369 2012-10-03

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Phase NA Completed

441 enrolled

Dermatologic

Melanoma, Skin Diseases, Skin Neoplasms, Hutchinson's Melanotic Freckle

NCT01161888 2012-06-20

LIMIT-1

Phase 4 Completed

30 enrolled

Hutchinson's Melanotic Freckle

Clinical Trials

Micro3

RADICAL

PICAMEL

DermaSense

Reflectance Confocal Microscopy to Diagnose MM & LM

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Mohs and Immunofluorescence for Malignant Melanoma In Situ

LM PDT

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

LIMIT-1